Results 241 to 250 of about 528,761 (298)

The effect of cuproptosis-related gene Atox1 on cardiac hypertrophy in heart failure was investigated based on bioinformatics analysis. [PDF]

Sci Rep
Zhou H, Yang M, Jin H, Ye Z.
europepmc   +1 more source

The common genetic variants of toll-like receptor and susceptibilityto adenoid hypertrophy: a hospital-based cohort study

, 2016
Mehmet Alı Babademez, Talih Özdaş, Sibel Özdaş   +2 more
openalex   +2 more sources

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Salivary and tonsillar microbiota across multiple sites in paediatric tonsillar hypertrophy and their associations with clinical factors. [PDF]

J Oral Microbiol
Xu Y, Yu M, Xu Y, Zhang F, Wang H, Zhang J, Gao X.   +6 more
europepmc   +1 more source

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

Cardiomyocyte Rac1 signaling in hypertrophy, arrhythmia, and cardiac stress adaptation. [PDF]

J Mol Cell Cardiol Plus
Teuber JP, Scissors RE, Brody MJ.
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Beyond Hypertrophy: A Case of Mid-ventricular Obstructive Hypertrophic Cardiomyopathy With Apical Sequestration. [PDF]

Cureus
Taoussi O, Scadi S, Mokhtari M, Benouna G, Merzouk F.   +4 more
europepmc   +1 more source

Clinical Application of Botulinum Toxin A for Calf Hypertrophy Followed by 3-Dimensional Computed Tomography

, 2018
Won Jong Oh, Tae‐Rin Kwon, Chang Taek Oh, Yang‐Soo Kim, Beom Joon Kim   +4 more
openalex   +1 more source